AUC |
area under curve |
BEAMing |
beads, emulsion, amplification, magnetics |
CA 19-9 |
carbohydrate antigen |
CDKN2A |
cyclin dependent kinase inhibitor 2A |
cfDNA |
circulating free DNA |
CK |
cytokeratin |
CP |
chronic pancreatitis |
CTCs |
circulating tumor cells |
CTEC |
tumor vascular endothelial cells |
ctDNA |
circulating tumor DNA |
DFS |
disease free survival |
DPC4 |
delete in Pancreatic Cancer-4 |
dPCR |
digital PCR |
ddPCR |
droplet digital PCR |
ECM |
extracellular matrix |
EMT |
epithelial–mesenchymal transition |
EpCAM |
epithelial cell adhesion |
EV |
extracellular vesicles |
FDA |
Food and Drug Administration |
GPC1 |
Glypican-1 |
KRAS |
Kristen rat sarcoma |
LB |
liquid biopsy |
MIF |
macrophage migration inhibitory factor |
miRNA |
micro-RNA |
MST |
median survival time |
NAC |
Neoadjuvant chemotherapy |
NGS |
next-generation sequencing |
OS |
overall survival |
PCR |
allele-specific polymerase chain reaction |
PDAC |
pancreatic ductal adenocarcinoma |
SMAD4 |
SMAD family member4 |
TEP |
tumor-educated platelet |
TP53 |
tumor protein 53 |